Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNYSE:JNJ
Previous Symbol
CUSIP47816010
Phone732-524-0400
Debt
Debt-to-Equity Ratio0.46
Current Ratio1.72
Quick Ratio1.40
Price-To-Earnings
Trailing P/E Ratio19.92
Forward P/E Ratio17.82
P/E Growth2.27
Sales & Book Value
Annual Sales$76.45 billion
Price / Sales5.10
Cash Flow$9.5615 per share
Price / Cash Flow15.21
Book Value$22.39 per share
Price / Book6.50
Profitability
EPS (Most Recent Fiscal Year)$7.30
Net Income$1.30 billion
Net Margins1.89%
Return on Equity34.62%
Return on Assets13.90%
Miscellaneous
Employees134,000
Outstanding Shares2,682,900,000
Market Cap$390.17 billion
OptionableOptionable
Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions
What is Johnson & Johnson's stock symbol?
Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."
How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?
Johnson & Johnson declared a quarterly dividend on Thursday, October 18th. Stockholders of record on Tuesday, November 27th will be paid a dividend of $0.90 per share on Tuesday, December 11th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 2.48%. The ex-dividend date is Monday, November 26th. View Johnson & Johnson's Dividend History.
How were Johnson & Johnson's earnings last quarter?
Johnson & Johnson (NYSE:JNJ) issued its quarterly earnings data on Tuesday, October, 16th. The company reported $2.05 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.02. The company had revenue of $20.35 billion for the quarter, compared to analysts' expectations of $20.05 billion. Johnson & Johnson had a net margin of 1.89% and a return on equity of 34.62%. Johnson & Johnson's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.90 earnings per share. View Johnson & Johnson's Earnings History.
When is Johnson & Johnson's next earnings date?
How can I listen to Johnson & Johnson's earnings call?
Johnson & Johnson will be holding an earnings conference call on Tuesday, January 22nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
What guidance has Johnson & Johnson issued on next quarter's earnings?
Johnson & Johnson issued an update on its FY18 earnings guidance on Monday, October, 29th. The company provided earnings per share (EPS) guidance of $8.13-8.18 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.16.
What price target have analysts set for JNJ?
16 analysts have issued 1-year price targets for Johnson & Johnson's stock. Their forecasts range from $110.00 to $161.00. On average, they anticipate Johnson & Johnson's stock price to reach $143.8333 in the next twelve months. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for Johnson & Johnson.
What is the consensus analysts' recommendation for Johnson & Johnson?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 1 sell rating, 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.
Has Johnson & Johnson been receiving favorable news coverage?
Media coverage about JNJ stock has trended positive on Monday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Johnson & Johnson earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future.
Who are some of Johnson & Johnson's key competitors?
Some companies that are related to Johnson & Johnson include Pfizer (PFE), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), AbbVie (ABBV), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Novo Nordisk A/S (NVO), Sanofi (SNY), AstraZeneca (AZN), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Shire (SHPG) and Allergan (AGN).
Who are Johnson & Johnson's key executives?
Johnson & Johnson's management team includes the folowing people:
- Alex Gorsky, Chairman & Chief Executive Officer
- Joseph J. Wolk, Chief Financial Officer & Executive Vice President
- Michael H. Ullmann, Executive Vice President & General Counsel
- Jennifer Taubert, EVP & Worldwide Chairman-Pharmaceuticals
- Peter M. Fasolo, Chief Human Resources Officer & Executive VP
Who are Johnson & Johnson's major shareholders?
Johnson & Johnson's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.96%), Bank of New York Mellon Corp (1.26%), Massachusetts Financial Services Co. MA (1.11%), Morgan Stanley (0.85%), Legal & General Group Plc (0.48%) and Fisher Asset Management LLC (0.42%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Dominic J Caruso, Joaquin Duato, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.
Which major investors are selling Johnson & Johnson stock?
JNJ stock was sold by a variety of institutional investors in the last quarter, including Mitsubishi UFJ Trust & Banking Corp, Fisher Asset Management LLC, American Century Companies Inc., Skandinaviska Enskilda Banken AB publ , Russell Investments Group Ltd., Massachusetts Financial Services Co. MA, Assenagon Asset Management S.A. and Janus Henderson Group PLC. Company insiders that have sold Johnson & Johnson company stock in the last year include Alex Gorsky, Joaquin Duato, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Insider Buying and Selling for Johnson & Johnson.
Which major investors are buying Johnson & Johnson stock?
JNJ stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Morgan Stanley, Los Angeles Capital Management & Equity Research Inc., Mondrian Investment Partners LTD, Cornerstone Wealth Management LLC, Flossbach Von Storch AG, Bank of New York Mellon Corp and Teachers Advisors LLC. View Insider Buying and Selling for Johnson & Johnson.
How do I buy shares of Johnson & Johnson?
Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Johnson & Johnson's stock price today?
One share of JNJ stock can currently be purchased for approximately $145.43.
How big of a company is Johnson & Johnson?
Johnson & Johnson has a market capitalization of $390.17 billion and generates $76.45 billion in revenue each year. The company earns $1.30 billion in net income (profit) each year or $7.30 on an earnings per share basis. Johnson & Johnson employs 134,000 workers across the globe.
What is Johnson & Johnson's official website?
How can I contact Johnson & Johnson?
Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.
MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
